vical

Biotech Stock News (EPZM) (VICL) (ALPMF) (CBLI) | CNA Finance

Epizyme (NASDAQ:EPZM)On June 22, 2015 shares of Epizyme were up about 27% after the company announced that it had obtained positive phase 1 results in patients with Non-Hodgkin’s Lymphoma — NHL. The company used its drug known as EPZ-6438, which is also known as tazemetostat to treat these patients with NHL. Epizyme has developed this drug to treat these NHL […]